Cargando…

A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification

Betulinic acid (BA) is a natural product that exerts its cytotoxicity against various malignant carcinomas without side effects by triggering the mitochondrial pathway to apoptosis. Betulin (BE), the 28-hydroxyl analog of BA, is present in large amounts (up to 30% dry weight) in the outer bark of bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Weimin, Sun, Miao, Luo, Shaman, Xu, Tao, Cao, Yibo, Yan, Xiufeng, Wang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270193/
https://www.ncbi.nlm.nih.gov/pubmed/23973995
http://dx.doi.org/10.3390/molecules180910228
_version_ 1783376641494351872
author Ding, Weimin
Sun, Miao
Luo, Shaman
Xu, Tao
Cao, Yibo
Yan, Xiufeng
Wang, Yang
author_facet Ding, Weimin
Sun, Miao
Luo, Shaman
Xu, Tao
Cao, Yibo
Yan, Xiufeng
Wang, Yang
author_sort Ding, Weimin
collection PubMed
description Betulinic acid (BA) is a natural product that exerts its cytotoxicity against various malignant carcinomas without side effects by triggering the mitochondrial pathway to apoptosis. Betulin (BE), the 28-hydroxyl analog of BA, is present in large amounts (up to 30% dry weight) in the outer bark of birch trees, and shares the same pentacyclic triterpenoid core as BA, yet exhibits no significant cytotoxicity. Topomer CoMFA studies were performed on 37 BA and BE derivatives and their in vitro anti-cancer activity results (reported as IC(50) values) against HT29 human colon cancer cells in the present study. All derivatives share a common pentacyclic triterpenoid core and the molecules were split into three pieces by cutting at the C-3 and C-28 sites with a consideration toward structural diversity. The analysis gave a leave-one-out cross-validation q(2) value of 0.722 and a non-cross-validation r(2) value of 0.974, which suggested that the model has good predictive ability (q(2) > 0.2). The contour maps illustrated that bulky and electron-donating groups would be favorable for activity at the C-28 site, and a moderately bulky and electron-withdrawing group near the C-3 site would improve this activity. BE derivatives were designed and synthesized according to the modeling result, whereby bulky electronegative groups (maleyl, phthalyl, and hexahydrophthalyl groups) were directly introduced at the C-28 position of BE. The in vitro cytotoxicity values of the given analogs against HT29 cells were consistent with the predicted values, proving that the present topomer CoMFA model is successful and that it could potentially guide the synthesis of new betulinic acid derivatives with high anti-cancer activity. The IC(50) values of these three new compounds were also assayed in five other tumor cell lines. 28-O-hexahydrophthalyl BE exhibited the greatest anti-cancer activities and its IC(50) values were lower than those of BA in all cell lines, excluding DU145 cells.
format Online
Article
Text
id pubmed-6270193
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62701932018-12-18 A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification Ding, Weimin Sun, Miao Luo, Shaman Xu, Tao Cao, Yibo Yan, Xiufeng Wang, Yang Molecules Article Betulinic acid (BA) is a natural product that exerts its cytotoxicity against various malignant carcinomas without side effects by triggering the mitochondrial pathway to apoptosis. Betulin (BE), the 28-hydroxyl analog of BA, is present in large amounts (up to 30% dry weight) in the outer bark of birch trees, and shares the same pentacyclic triterpenoid core as BA, yet exhibits no significant cytotoxicity. Topomer CoMFA studies were performed on 37 BA and BE derivatives and their in vitro anti-cancer activity results (reported as IC(50) values) against HT29 human colon cancer cells in the present study. All derivatives share a common pentacyclic triterpenoid core and the molecules were split into three pieces by cutting at the C-3 and C-28 sites with a consideration toward structural diversity. The analysis gave a leave-one-out cross-validation q(2) value of 0.722 and a non-cross-validation r(2) value of 0.974, which suggested that the model has good predictive ability (q(2) > 0.2). The contour maps illustrated that bulky and electron-donating groups would be favorable for activity at the C-28 site, and a moderately bulky and electron-withdrawing group near the C-3 site would improve this activity. BE derivatives were designed and synthesized according to the modeling result, whereby bulky electronegative groups (maleyl, phthalyl, and hexahydrophthalyl groups) were directly introduced at the C-28 position of BE. The in vitro cytotoxicity values of the given analogs against HT29 cells were consistent with the predicted values, proving that the present topomer CoMFA model is successful and that it could potentially guide the synthesis of new betulinic acid derivatives with high anti-cancer activity. The IC(50) values of these three new compounds were also assayed in five other tumor cell lines. 28-O-hexahydrophthalyl BE exhibited the greatest anti-cancer activities and its IC(50) values were lower than those of BA in all cell lines, excluding DU145 cells. MDPI 2013-08-22 /pmc/articles/PMC6270193/ /pubmed/23973995 http://dx.doi.org/10.3390/molecules180910228 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Ding, Weimin
Sun, Miao
Luo, Shaman
Xu, Tao
Cao, Yibo
Yan, Xiufeng
Wang, Yang
A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification
title A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification
title_full A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification
title_fullStr A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification
title_full_unstemmed A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification
title_short A 3D QSAR Study of Betulinic Acid Derivatives as Anti-Tumor Agents Using Topomer CoMFA: Model Building Studies and Experimental Verification
title_sort 3d qsar study of betulinic acid derivatives as anti-tumor agents using topomer comfa: model building studies and experimental verification
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270193/
https://www.ncbi.nlm.nih.gov/pubmed/23973995
http://dx.doi.org/10.3390/molecules180910228
work_keys_str_mv AT dingweimin a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT sunmiao a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT luoshaman a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT xutao a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT caoyibo a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT yanxiufeng a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT wangyang a3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT dingweimin 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT sunmiao 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT luoshaman 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT xutao 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT caoyibo 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT yanxiufeng 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification
AT wangyang 3dqsarstudyofbetulinicacidderivativesasantitumoragentsusingtopomercomfamodelbuildingstudiesandexperimentalverification